4th Quarter - Report

FINSTON CONSULTING, LLC for AMERICAN BIOINDUSTRY ALLIANCE (ALSO KNOWN AS ABSA)

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

To encourage the Congress and the Executive Branch to oppose any attempts by foreign governments to negotiate new international agreements or to amend existing intellectual property agreements in the WTO and WIPO to weaken patent protection for biotechnology inventions. To encourage the Congress and the Executive Branch to oppose the inclusion of new, additional disclosure requirements for the patenting of life sciences inventions in any Access and Benefit Sharing (ABS) regime in the CBD.

LobbyistCovered position, as disclosed
SUSAN KLING FINSTON —

Contacted: Executive Office of the President (EOP); State, Dept of (DOS); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Agriculture, Dept of (USDA); Smithsonian Institution

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.